“Other (expense) income, net Other (expense) income, net decreased by $0.6 million for the three months ended March 31, 2026, compared to the same period in 2025, primarily due to foreign exchange losses during the period.”10-Q · Apr 28, 2026 ↗
CareDx, Inc.
CDNA
Market read
CareDx, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.
- CDNA's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if CDNA's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- CDNA's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +13.8% year over year.
- Foreign exchange has repeated favorable evidence across 4 filings.
- Operating margin changed -20.3 percentage points in the latest annual period.
- Net margin changed -21.4 percentage points in the latest annual period.
- EV/sales is 58% below the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 10, 2026
49.97Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“Cash Flows from Investing Activities For the year ended December 31, 2025, net cash provided by investing activities was $2.2 million and primarily related to maturities of marketable securities of $154.7 million, partially offset by purchase of marketable se…”10-K · Feb 25, 2026 ↗
“The decrease in litigation settlement expense was mainly due to the settlement of $5.4 million related to the Securities Class Action lawsuit during the three months ended March 31, 2025, which was partially offset by a $0.6 million settlement related to the…”10-Q · Apr 28, 2026 ↗
“The decrease was primarily due to lower sales and improved manufacturing efficiencies and lower costs resulting from favorable pricing terms negotiated with key manufacturers.”10-Q · Apr 28, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 7.0× · EV/sales 6.8×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for CDNA. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for CDNA. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind CDNA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BDXBecton, Dickinson and CompanysupplierApr 28, 2026 ▾
“These sole source suppliers include Thermo Fisher Scientific, Inc., or Thermo Fisher, which supplies us with instruments, laboratory reagents and consumables; Roche Molecular Systems, which supplies us with laboratory reagents and consumables; Hamilton Roboti…”
ILMNIllumina, Inc.supplierApr 28, 2026 ▾
“These sole source suppliers include Thermo Fisher Scientific, Inc., or Thermo Fisher, which supplies us with instruments, laboratory reagents and consumables; Roche Molecular Systems, which supplies us with laboratory reagents and consumables; Hamilton Roboti…”
Depended on by
NTRANatera, Inc.competitorFeb 27, 2026 ▾
“In organ health, our primary competitor is CareDx, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CDNA is currently a Follower in the organic co-movement group Consumer Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for CDNA; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.